Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company H3 Biomedicine Inc.
DescriptionOral inhibitor of fibroblast growth factor receptor 4 (FGFR4)
Molecular Target Fibroblast growth factor (FGF) receptor 4 (FGFR4) (CD334)
Mechanism of ActionFibroblast growth factor (FGF) receptor 4 (FGFR4) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationLiver cancer
Indication DetailsTreat advanced hepatocellular carcinoma (HCC); Treat intrahepatic cholangiocarcinoma
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today